Vaccines
Studies from Novartis in the Area of Vaccines Published
Published in Vaccine Weekly, January 26th, 2011
2011 JAN 26 -- Investigators publish new data in the report 'Vi-CRM 197 as a new conjugate vaccine against Salmonella Typhi.' "An efficacious, low cost vaccine against typhoid fever, especially for young children, would make a major impact on disease burden in developing countries. The virulence capsular polysaccharide of Salmonella typhi (Vi) coupled to recombinant mutant Pseudomonas aeruginosa exoprotein A (Vi-rEPA) has been shown to be highly efficacious," scientists in Siena, Italy report.
"We investigated the use of carrier proteins included in infant vaccines, standardized the conjugation process and developed key assays required for...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2011-01-26)
More Articles from Vaccine Weekly
- Vaccines
Scientists at Iowa State University Target Vaccines - Hepatitis B Virus
Studies from Health Protection Agency Center for Infections Provide New Data on Hepatitis B Virus - Health Services Research
Studies from Muhimbili University in the Area of Health Services Research Described - Bacillus anthracis
'Bacillus anthracis and Anthrax' - Viral Vaccines
Data from University of Texas Advance Knowledge in Viral Vaccines - Alzheimer Vaccines
Data on Alzheimer Vaccines Reported by Researchers at Graduate School - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
